DBV Technologies price target raised to $47 from $45 at Citizens

Citizens raised the firm’s price target on DBV Technologies (DBVT) to $47 from $45 and keeps an Outperform rating on the shares. DBV Technologies remains on track to submit its BLA for Viaskin Peanut in peanut allergic 4-7 year olds in 1H26, the analyst tells investors in a research note. The firm thinks approval next year is likely.